Chinnampalli, K.V. 2026. FROM RISK TO QUALITY: QUALITY RISK MANAGEMENT IN PHARMA TARGETING CANCER THROUGH IMMUNE MODULATION . Biospecia. 2, 2 (May 2026), 13–17.